Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphopenia 1Esophageal Neoplasms 1

Interventions

Specimen Handling 655pembrolizumab 605Magnetic Resonance Spectroscopy 562Carboplatin 445Cisplatin 396Cyclophosphamide 394Biopsy 378Nivolumab 323Paclitaxel 320Gemcitabine 313Radiotherapy 293Bevacizumab 248Dexamethasone 221fludarabine 212Docetaxel 201durvalumab 193atezolizumab 186Oxaliplatin 186venetoclax 182Fluorouracil 175Rituximab 173Pemetrexed 172Capecitabine 170Radiation 166Doxorubicin 166Radiosurgery 158Ipilimumab 145Etoposide 142Leucovorin 140Lenalidomide 137

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
SARS-CoV-2 inactivated vaccines × 90 days × Clear all
NCT06181656 2026-05-20

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

M.D. Anderson Cancer Center

Recruiting
80 enrolled
Gastrointestinal

Esophageal Neoplasms, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡